Consensus document on controversial issues for the treatment of infections of the central nervous system: bacterial brain abscesses

International Journal of Infectious Diseases

Volumn 14, Issue SUPPL. 4, 2010, Pages

  Arlotti, Massimo ^a   Grossi, Paolo ^b   Pea, Federico ^c   Tomei, Giustino ^b   Vullo, Vincenzo ^d   De Rosa, Francesco G ^e   Di Perri, Giovanni ^e   Nicastri, Emanuele ^f,i   Lauria, Francesco N ^f,i   Carosi, Giampiero ^g,i   Moroni, Mauro ^h,i   Ippolito, Giuseppe ^f,i  

^a Department of Internal Medicine I   (Italy)

^b OSPEDALE DI CIRCOLO   (Italy)

^c UNIVERSITY OF UDINE   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e UNIVERSITY OF TURIN   (Italy)

^f NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^g UNIVERSITY OF BRESCIA   (Italy)

^h UNIVERSITY OF MILAN   (Italy)

ⁱ GISIG Gruppo Italiano di Studio sulle Infezioni Gravi Coordinating Committee   (Italy)

Author keywords

Brain abscesses; Brain antibiotic diffusion; Conservative medical approach; Surgical approach

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; ANTIBIOTIC AGENT; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CIPROFLOXACIN; CLOXACILLIN; COTRIMOXAZOLE; FLUCLOXACILLIN; FUSIDIC ACID; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; LINEZOLID; MEROPENEM; METRONIDAZOLE; MOXIFLOXACIN; NAFCILLIN; PEFLOXACIN; PENICILLIN G; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; RIFAMPICIN; SULTAMICILLIN; THIAMPHENICOL; UNINDEXED DRUG; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; BRAIN ABSCESS; CENTRAL NERVOUS SYSTEM INFECTION; CLINICAL PRACTICE; CLINICAL PROTOCOL; COMPUTER ASSISTED TOMOGRAPHY; CONSENSUS DEVELOPMENT; CRANIOTOMY; DRUG CHOICE; DRUG COST; DRUG EFFICACY; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAPHY; ERADICATION THERAPY; EXCISION; HUMAN; ITALY; LEUKOPENIA; LOADING DRUG DOSE; MINIMUM INHIBITORY CONCENTRATION; NEUROIMAGING; NEUROSURGERY; PATIENT SAFETY; PRACTICE GUIDELINE; PRURITUS; QUALITY OF LIFE; RASH; RECOMMENDED DRUG DOSE; SINGLE DRUG DOSE; SUBDURAL EMPYEMA; SURGICAL APPROACH; TREATMENT OUTCOME;

ADOLESCENT; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BRAIN ABSCESS; CHILD; CHILD, PRESCHOOL; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; INFANT; MALE; RETROSPECTIVE STUDIES;

EID: 78149280304     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijid.2010.05.010     Document Type: Article

References (70)

1. Yildizhan A., Paşaoĝlu A., Ozkul M.H., Aral O., Ozkul N. Clinical analysis and results of operative treatment of 41 brain abscesses. Neurosurg Rev 1991, 14:279-282.
2. Carpenter J., Stapleton S., Holliman R. Retrospective analysis of 49 cases of brain abscess. Eur J Clin Microbiol Infect Dis 2007, 26:1-11.
3. Wong T.T., Lee L.S., Wang H.S., Shen E.Y., Jaw W.C., Chiang C.H., et al. Brain abscess in children-a cooperative study of 83 cases. Childs Nerv Syst 1989, 5:19-24.
4. Cavuşoglu H., Kaya R.A., Türkmenoglu O.N., Colak I., Aydin Y. Brain abscess: analysis of results in a series of 51 patients with a combined surgical and medical approach during an 11-year period. Neurosurg Focus 2008, 24:1-7.
5. Kondziolka D., Duma C.M., Lunsford L.D. Factors that enhance the likelihood of successful stereotactic treatment of brain abscess. Acta Neurochir (Wien) 1994, 127:85-90.
6. Xiao F., Tseng M.Y., Teng L.J., Tseng H.M., Tsai J.C. Brain abscess: clinical experience and analysis of prognostic factors. Surg Neurol 2005, 63:442-450.
7. De Louvois J., Brown E.M., Bayston R., Lees P.D., Pople I.K. The rationale use of antibiotics in the treatment of brain abscess. Br J Neurosurg 2000, 14:525-530.
8. Leys D., Christiaens J.L., Derambure P., Hladky J.P., Lesoin F., Rousseaux M., et al. Management of focal intracranial infections: is medical treatment better than surgery?. J Neurol Neurosurg Psychiatry 1990, 53:472-475.
9. Lauria F.N., De Carli G., Nicastri E. Resistant and multi-resistant Gram-positive severe infections: the GISIG working methodology. Int J Infect Dis 2010, 14:S13-S17.
10. Tseng J.H., Tseng M.Y. Brain abscess in 142 patients: factors influencing outcome and mortality. Surg Neurol 2006, 65:557-562.
11. Hakan T., Ceran N., Erdem I., Berkman M.Z., Göktaş P. Bacterial brain abscess: an evaluation of 96 cases. J Infect 2006, 52:359-366.
12. Mampalan T.J., Rosemblum M.L. Trends in the management of bacterial brain abscess: a review of 102 cases in 17 years. Neurosurgery 1988, 23:451-458.
13. Qureshi H.U., Habib A.A., Siddiqui A.A., Mozaffar T., Sarwari A.R. Predictors of mortality of brain abscess. J Pak Med Assoc 2002, 52:111-116.
14. Russeaux M., Lesoin F., Destee A., Jomin N., Petit H. Long term sequelae of hemispheric abscess as a function of the treatment. Acta Neurochir (Wien) 1985, 74:61-67.
15. Schliamser S.E., Backman K., Ragnar Norby S. Intracranial abscesses in adults: an analysis of 54 consecutive cases. Scand J Infect Dis 1988, 20:1-9.
16. Ferriero D.M., Derechin M., Edwards M.S., Berg B.O. Outcome of brain abscess in children: reduced morbidity with neuroimaging. Pediatr Neurol 1987, 3:148-152.
17. Chun C.H., Johnson J.D., Hofstetter M., Raff M.J. Brain abscess. A study of 45 consecutive cases. Medicine (Baltimore) 1986, 65:415-431.
18. Dashti S.R., Baharvhdat H., Spetzler R.F., Sauvageau E., Chang S.W., Stiefel M., et al. Operative intracranial infection following craniotomy. Neurosurg Focus 2008, 24:1-4.
19. Sichizya K., Fieggen G., Taylor A., Peter J. Brain abscesses. The Groote Schuur experience, 1993-2003. S Afr J Surg 2005, 43:79-82.
20. McLelland S., Hall W.A. Postoperative central nervous system infections: incidence and associated factors in 2111 surgical procedures. Clin Infect Dis 2007, 45:55-59.
21. Tekkök Ĥ, Erbengy A. Management of brain abscess in children: review of 130 cases over a period of 21 years. Childs Nerv Syst 1992, 8:411-416.
22. Domingo Z., Peter J.C. Brain abscess in childhood. A 25-year experience. S Afr Med J 1994, 84:13-15.
23. Kowlessar P.I., O'Connel N.H., Mitchell R.D., Elliot S., Elliott T.S. Management of patients with Streptococcus milleri brain abscesses. J Infect 2006, 52:443-450.
24. Huda F, Sharma V, Mohammad Ali W, Rashid M. Gram-negative bacillary brain abscess: clinical features and therapeutic outcome. Internet J Neurosurg 2007; 4:2; available at: (accessed August 19, 2009)
25. Lumbiganon P., Chaikitpinyo A. Antibiotics for brain abscesses in people with cyanotic congenital hart disease. Cochrane Database Syst Rev 2007, 3:1-13.
26. Jansson A.K., Emblad P., Sjölin J. Efficacy and safety of cefotaxime in combination with metronidazole for empirical treatment of brain abscess in clinical practice: a retrospective study of 66 consecutive cases. Eur J Clin Microbiol Infect Dis 2004, 23:7-14.
27. Sjölin J., Lilja A., Eriksson N., Arnebon P., Cars O. Treatment of brain abscess with cefotaxime and metronidazole: prospective study of 15 consecutive patients. Clin Infect Dis 1993, 17:857-863.
28. Akova M., Hakalìn H.E., Korten V., Özgen T., Erbengi A. Treatment of intracranial abscesses: experience with sulbactam/ampicillin. J Chemother 1993, 5:181-185.
29. Rau C.S., Chang W.N., Lyn Y.C., Lu C.H., Liliang P.C., Su T.M., et al. Brain abscess caused by aerobic Gram- negative bacilli: clinical features and therapeutic outcomes. Clin Neurol Neurosurg 2002, 105:60-65.
30. Tayfun H., Nürgul C., Ilknur E., Mehemet Zafer B., Paşa G. Bacterial brain abscesses: An evaluation of 96 cases. J Infect 2006, 52:359-366.
31. Javad A., Vahid P., Kazem G., Alireza S., Gholamali G., Qulamreza K. Piperacillin/tazobactam in the treatment of brain abscess. Scand J Infect Dis 2006, 38:224-226.
32. Ntziora F., Falagas M.E. Linezolid for the treatment of central nervous system infections. Ann Pharmacother 2007, 41:296-308.
33. Malacarne P., Viaggi B., Di Paolo A., Danesi R., Del Tacca M. Linezolid cerebrospinal fluid concentration in central nervous system infections. J Chemother 2007, 19:90-93.
34. Myrianthefs P., Markantonis S.L., Vlachos K., Anagnostaki M., Boutzouka E., Panidis D., et al. Serum and cerebrospinal fluid concentration of linezolid in neurosurgical patients. Antimicrob Agents Chemother 2006, 50:3971-3976.
35. Sjölin J., Eriksson N., Arneborn P., Cars O. Penetration of cefotaxime and desacetylcefotaxime into brain abscesses in humans. Antimicrob Agents Chemother 1991, 35:2606-2610.
36. Green H.T., O'Donoghue M.A., Shaw M.D., Dowling C. Penetration of ceftazidime into intracranial abscess. J Antimicrob Chemother 1989, 24:431-436.
37. Asensi V., Cartón J.A., Maradona J.A., Asensi J.M., Pérez F., Redondo P., et al. Therapy of brain abscess with imipenem-a safe therapeutic choice?. J Antimicrob Chemother 1996, 37:200-203.
38. Mindermann T., Zimmerli W., Rajacic Z., Gratzl O. Penetration of fusidic acid into human brain tissue and cerebrospinal fluid. Acta Neurochir (Wien) 1993, 121:12-14.
39. Padney P., Umesh S., Bhat D., Srinivas D., Abraham R., Pillai S., et al. Cerebellar abscesses in children: excision or aspiration?. J Neurosurg Pediatr 2008, 1:31-34.
40. Renier D., Fladin C., Hirsh E., Hirsh J.F. Brain abscesses in neonates. A study of 30 cases. J Neurosurg 1988, 69:877-882.
41. Mamelak A., Mampalan T., Obana W., Rosemblum M. Improved management of multiple brain abscesses: a combined surgical and medical approach. Neurosurgery 1995, 36:76-86.
42. Kocherry X., Hegde T., Sastry K., Mohanty A. Efficacy of stereotactic aspiration in deep-seated and eloquent-region intracranial pyogenic abscesses. Neurosurg Focus 2008, 24:E13.
43. Moss D.S., McLone D., Arditi M., Yogev R., et al. Pediatric cerebral abscess. Pediatr Neurosci 1988, 14:291-296.
44. Erşain Y., Mutluer S., Güzelbaĝ E. Brain abscess in infant and children. Childs Nerv Syst 1994, 10:185-189.
45. Srinivasan U., Gajendran R., Joseph M.J. Pyogenic brain abscess managed by repeated elective aspiration. Neurol India 1999, 47:202-205.
46. Gupta S., Mohanty S., Tandon S., Asthana S. Brain abscess: with special references to infection by Pseudomonas. Br J Neurosurg 1990, 4:279-286.
47. Barlas O., Sencer A., Erkan K., Heraksoy K., Sencer S., Bayindir Ç. Stereotactic surgery in the management of brain abscess. Surg Neurol 1999, 52:404-411.
48. Lunardi P., Aqui M., Ferrante L., Mastronardi L., Fortuna A. Non traumatic brain abscess. Neurosurg Rev 1993, 16:189-196.
49. Menhaz A., Syed A.U., Saleem A.S., Khalid C.N. Clinical features and outcome of cerebral abscess in congenital heart disease. J Ayub Med Coll Abbottabad 2006, 18:21-24.
50. Seydoux C., Francioli P. Bacterial brain abscess: factors influencing mortality and sequelae. Clin Infect Dis 1992, 15:394-401.
51. Brindon H., Hardwidge C. The management of cerebellar abscess since the introduction of CT scanning. Br J Neurosurg 1994, 8:447-455.
52. Aydin I.H., Aladag M.A., Kadioglu H.H., Önder A. Clinical analysis of cerebral abscesses. Zentralbl Neurochir 1988, 49:210-219.
53. Bhand A.A. Brain abscess-diagnosis and treatment. J Coll Physicians Surg Pak 2004, 14:407-410.
54. Manfredi R., Sabbatani S., Marinacci G., Salizzoni E., Chiodo F. Listeria monocytogenes meningitis and brain abscesses in an immunocompetent host. Favorable response to combination linezolid-meropenem treatment. J Chemother 2006, 18:331-333.
55. Leiti O., Gross J.W., Tuazon C.U. Treatment of brain abscess caused by Listeria monocytogenes in a patient with allergy to penicillin and trimethoprim-sulfamethoxazole. Clin Infect Dis 2005, 40:206-207.
56. Boak L.M., Li J., Spelman D., Du Cross P., Nation R.L., Rayner C.R. Successful treatment and cerebrospinal fluid penetration of oral linezolid in a patient with coagulase-negative Staphylococcus ventriculitis. Ann Pharmacother 2006, 40:151-155.
57. Salin F., Vianello F., Manara R., Morelli E., Cattellan A., Scarin M., et al. Linezolid in the treatment of brain abscess due to Peptostreptococcus. Scand J Infect Dis 2006, 38:203-205.
58. Kumar S., Kholhoff S., Valencia G., Hammerschlag M.R. Treatment of vancomycin-resistant Enterococcus faecium ventriculitis in a neonate. Int J Antimicrob Agents 2007, 29:740.
59. Raza M.W., Shad A., Pedler S.J., Karamal K.A. Penetration and activity of antibiotics in brain abscess. J Coll Physicians Surg Pak 2005, 15:165-167.
60. Lo W.D., Wolny A., Boesel C. Blood-brain barrier permeability in staphylococcal cerebritis and early brain abscess. J Neurosurg 1994, 80:897-905.
61. Nau R., Sorgel F., Prange H.W. Pharmacokinetic optimization of the treatment of bacterial central nervous system infections. Clin Pharmacokinet 1998, 35:223-246.
62. Nau R., Prange H.W., Menck S., Kolenda H., Visser K., Seydel J.K. Penetration of rifampin into the cerebrospinal fluid of adults with uninflamed meninges. J Antimicrob Chemother 1992, 29:719-724.
63. Pea F., Pavan F., Nascimben E., Benetton C., Scotton P.G., Vaglia A., et al. Levofloxacin disposition in cerebrospinal fluid in patients with external ventriculostomy. Antimicrob Agents Chemother 2003, 47:3104-3108.
64. Kanellakopoulou K., Pagoulatou A., Stroumpoulis K., Vafiadou M., Kranidioti H., Giamarellou H., et al. Pharmacokinetics of moxifloxacin in non-inflamed cerebrospinal fluid of humans: implication for a bactericidal effect. J Antimicrob Chemother 2008, 61:1328-1331.
65. Nau R., Prange H.W., Kinzig M., Frank A., Dressel A., Sholz P., et al. Cerebrospinal fluid ceftazidime kinetics in patients with external ventriculostomies. Antimicrob Agents Chemother 1996, 40:763-766.
66. Nau R., Lassek C., Kinzig-Schippers M., Thiel A., Hilmar P., Sörgel F. Disposition and elimination of meropenem in cerebrospinal fluid of hydrocephalic patients with external ventriculostomy. Antimicrob Agents Chemother 1998, 42:2012-2016.
67. Albanese J., Leone M., Bruguerolle B., Ayem M.L., Lacarelle B., Martin C. Cerebrospinal fluid penetration and pharmacokinetics of vancomycin administered by continuous infusion to mechanically ventilated patients in an intensive care unit. Antimicrob Agents Chemother 2000, 44:1356-1358.
68. Chaudhuri A., Martinez-Martin P., Kennedy P.G., Andrew S.R., Portegies P., Bojar M., et al. EFNS guideline on the management of community-acquired bacterial meningitis: report of an EFNS task force on acute bacterial meningitis in older children and adults. Eur J Neurol 2008, 15:649-659.
69. Hirsh J.F., Roux F.X., Sainte-Rose C., Renier D., Pierre Khan A. Childs Brain 1983, 10:251-265.
70. Kao P-T., Tseng H-K., Liu C-P., Su C-S., Lee C-M. J Microbiol Immunol Infect 2003, 36:129-136.